Flavin-dependant thymidylate synthases (FDTSs) are a class of recently identified family of thymidylate synthases that employ novel mechanism for the thymidylate synthase reaction. Thymidylate synthases use N5,N10-methylene-5,6,7,8-tetrahydrofolate (CH2H4folate) to reductively methylate 2’-deoxyuridine-5’-monophosphate (dUMP) producing 2’-deoxythymine-5’-monophosphate (dTMP). dTMP is one of the four DNA building blocks and is crucial for survival of all organisms. Unlike other deoxynucleotides, dTMP cannot be directly synthesized by a ribonucleotide reductase, and its de novo biosynthesis requires the enzyme thymidylate synthase. Therefore, inhibition of thymidylate synthesis stops DNA production, arresting cell cycle and eventually leading to “thymineless” cell death. The human enzyme has long been recognized as a target for anticancer drugs.
Since FDTS enzymes are mainly found in very pathogenic microbes including the pathogens causing leprosy, botulism, diarrhea, anthrax, pneumonia, syphilis, etc., the FDTS enzyme is an attractive target for antibiotic drugs.